Last reviewed · How we verify

NCT04315168

FRED and FRED JR Devices for Intracranial Aneurysm Treatment

Completed Last updated 23 January 2024
What this trial tests

trial testing FRED and FRED JR in Intracranial Aneurysm in 135 participants. Completed in 31 December 2023.

Timeline
12 June 2020
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorMicrovention-Terumo, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment135
Start date12 June 2020
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Microvention-Terumo, Inc. — full company profile →

Who can join

Eligibility, any sex, with Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A French, multicenter, prospective, observational, "real-world" assessment of the safety and efficacy of FRED and FRED Jr devices in the treatment of intracranial aneurysms

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intracranial Aneurysm

Currently open trials in the same condition.

Other Microvention-Terumo, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04315168.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing